|
ATXN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.437160E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.217820E-02 |
| Normal-vs-Stage2 |
3.115400E-03 |
| Normal-vs-Stage3 |
1.397850E-03 |
| Normal-vs-Stage4 |
2.419000E-03 |
| Stage1-vs-Stage2 |
1.230420E-01 |
| Stage1-vs-Stage3 |
1.943160E-01 |
| Stage1-vs-Stage4 |
2.180200E-01 |
| Stage2-vs-Stage3 |
5.692200E-01 |
| Stage2-vs-Stage4 |
7.461000E-01 |
| Stage3-vs-Stage4 |
8.152600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.560700E-03 |
| Normal-vs-AfricanAmerican |
9.832200E-02 |
| Normal-vs-Asian |
1.431990E-01 |
| Caucasian-vs-AfricanAmerican |
8.741600E-01 |
| Caucasian-vs-Asian |
2.852800E-01 |
| AfricanAmerican-vs-Asian |
5.678000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.064610E-03 |
| Normal-vs-Female |
3.639300E-03 |
| Male-vs-Female |
3.466800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.705500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.215900E-04 |
| Normal-vs-Age(61-80Yrs) |
5.8330999999967E-05 |
| Normal-vs-Age(81-100Yrs) |
3.689000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.838100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.141300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.239400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.377400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.476200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.645200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.916600E-01 |
| Classical-VS-Follicular |
2.14829999999333E-05 |
| Classical-VS-Other |
4.250800E-01 |
| Classical-VS-Normal |
3.093600E-02 |
| Tall-VS-Follicular |
4.108400E-02 |
| Tall-VS-Other |
5.866200E-01 |
| Tall-VS-Normal |
9.635800E-02 |
| Follicular-VS-Other |
5.614000E-01 |
| Follicular-VS-Normal |
1.80207000000099E-05 |
| Other-VS-Normal |
1.536000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.6286000000052E-05 |
| Normal-vs-N1 |
3.628400E-02 |
| N0-vs-N1 |
1.971040E-01 |
|
|
